Canada markets open in 8 hours 32 minutes

Xcorporeal, Inc. (XCRP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0000-0.0001 (-99.00%)
At close: 02:53PM EDT

Xcorporeal, Inc.

80 Empire Drive
Lake Forest, CA 92630
United States
949 600 4621

Sector(s)
Industry
Full Time Employees24

Key Executives

NameTitlePayExercisedYear Born
Dr. Victor Gura M.D.Chief Scientific Officer, Chief Medical Officer and Member of Board of Advisors455.6kN/A1943
Mr. Len BraganzaVice President of Sales & MarketingN/AN/AN/A
Amounts are as of December 31, 2008 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs. Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California.

Corporate Governance

Xcorporeal, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.